Menu

• Ask a Health Expert about INJECTION SITE DISCOLOURATION
• Post Your Side Effect related to INJECTION SITE DISCOLOURATION
• INJECTION SITE DISCOLOURATION and FDA Warnings
• INJECTION SITE DISCOLOURATION in Patients Wiki
• Report INJECTION SITE DISCOLOURATION in Drug Side Effect Survey

INJECTION SITE DISCOLOURATION side effect

What is INJECTION SITE DISCOLOURATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Humira Side Effects Report #5668274-7
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Feb 21, 2008. Female patient, weighting 142.1 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site nodule, injection site pruritus, injection site rash, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, LISINOPRIL. Patient recovered.

Rebif Side Effects Report #5689574-0
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site pain, injection site reaction, injection site scab, ovarian cyst, . REBIF dosage: unknown. During the same period patient was treated with METFORMIN, ALBUTEROL, SINGULAIR, CELEXA, BACLOFEN. Patient recovered.

Imitrex Side Effects Report #5638602-7
Consumer or non-health professional from UNITED STATES reported IMITREX problem on June 26, 2007. Male patient, 30 years of age, was diagnosed with migraine and was treated with IMITREX. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site pain, . IMITREX dosage: 6MG AS REQUIRED. During the same period patient was treated with BENTYL, LEXAPRO, PREVACID, KEPPRA, INDERAL, PHENERGAN. Patient recovered.

Rebif Side Effects Report #5593350-7
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient, 46 years of age, weighting 218.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, oedema peripheral, pain in extremity, . REBIF dosage: unknown. During the same period patient was treated with CYMBALTA, CRESTOR. Patient recovered.


Humira Side Effects Report #5559605-7
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Oct 09, 2007. Female patient, weighting 160.1 lb, was diagnosed with rheumatoid arthritis, contraception and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site haemorrhage, injection site swelling, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, DROSPIRENONE W, VITAMIN. Patient recovered.

Humira Side Effects Report #5560013-3
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Female patient, weighting 128.1 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site reaction, . HUMIRA dosage: unknown. Patient recovered.

Humira Side Effects Report #5560572-0
Consumer or non-health professional from reported HUMIRA problem on Nov 14, 2007. Female patient, weighting 233.7 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, . HUMIRA dosage: unknown. During the same period patient was treated with BETABLOCKER, DEXAMETHASONE, LEVOTHYROXINE, VENLAFAXIINE. Patient recovered.

Humira Side Effects Report #5560946-8
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2007. Female patient, weighting 151.1 lb, was diagnosed with crohn's disease, asthma, migraine, blood calcium decreased, pain and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, injection site rash, injection site warmth, . HUMIRA dosage: unknown. During the same period patient was treated with ADVAIR, GABAPENTIN, PREDNISONE, ALBUTEROL, CALCIUM, VICODIN. Patient recovered.

Aplisol Side Effects Report #5566055-6
Pharmacist from UNITED STATES reported APLISOL problem on Feb 05, 2007. Female patient was diagnosed with tuberculin test and was treated with APLISOL. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, . APLISOL dosage: .1 ML, UNK. Patient recovered.


Rebif Side Effects Report #5503961-2
REBIF problem was reported by a Pharmacist from UNITED STATES on Oct 30, 2007. Female patient was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, injection site infection, injection site necrosis, injection site pruritus, injection site urticaria, . REBIF dosage: unknown. Patient recovered.

Levemir Side Effects Report #5508033-9
Health Professional from UNITED STATES reported LEVEMIR problem on July 17, 2007. Male patient, 53 years of age, weighting 274.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site pruritus, . LEVEMIR dosage: unknown. Patient recovered.

Copaxone Side Effects Report #5416687-0
COPAXONE problem was reported by a Health Professional from GERMANY on July 30, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, injection site inflammation, injection site irritation, injection site necrosis, injection site pain, injection site scar, leukocytoclastic vasculitis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D). Patient was hospitalized. Patient recovered.

Norvir Side Effects Report #5376838-3
Health Professional from FRANCE reported NORVIR problem on June 26, 2007. Male patient, 46 years of age, weighting 180.8 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with NORVIR. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erosion, injection site pustule, oedema peripheral, skin ulcer, . NORVIR dosage: unknown. During the same period patient was treated with BUPRENORPHINE CHLORHYDRATE, LAMIVUDINE, TENOFOVIR DISOPROXIL, ATAZANAVIR SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.

Dalacin Side Effects Report #5383203-1
DALACIN problem was reported by a Physician from INDIA on June 28, 2007. Male patient, 18 years of age, was treated with DALACIN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, pilonidal cyst, . DALACIN dosage: unknown. Patient recovered.


Fuzeon Side Effects Report #5394139-4
Physician from BRAZIL reported FUZEON problem on July 11, 2007. Male patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site nodule, injection site pain, injection site swelling, oesophageal candidiasis, . FUZEON dosage: unknown. During the same period patient was treated with LAMIVUDINE, KALETRA. Patient was hospitalized. Patient recovered.

Norvir Side Effects Report #5376838-3
NORVIR problem was reported by a Health Professional from FRANCE on June 26, 2007. Male patient, 46 years of age, weighting 180.8 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with NORVIR. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erosion, injection site pustule, oedema peripheral, skin ulcer, . NORVIR dosage: unknown. During the same period patient was treated with BUPRENORPHINE CHLORHYDRATE, LAMIVUDINE, TENOFOVIR DISOPROXIL, ATAZANAVIR SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.

Dalacin Side Effects Report #5383203-1
Physician from INDIA reported DALACIN problem on June 28, 2007. Male patient, 18 years of age, was treated with DALACIN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, pilonidal cyst, . DALACIN dosage: unknown. Patient recovered.

Fuzeon Side Effects Report #5394139-4
FUZEON problem was reported by a Physician from BRAZIL on July 11, 2007. Male patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site nodule, injection site pain, injection site swelling, oesophageal candidiasis, . FUZEON dosage: unknown. During the same period patient was treated with LAMIVUDINE, KALETRA. Patient was hospitalized. Patient recovered.

Betaferon Side Effects Report #5763538-0
Consumer or non-health professional from BRAZIL reported BETAFERON problem on June 05, 2008. Female patient, 20 years of age, was diagnosed with multiple sclerosis and was treated with BETAFERON. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, injection site haemorrhage, injection site necrosis, injection site nodule, . BETAFERON dosage: unknown. Patient recovered.


Kenalog Side Effects Report #5765272-X
KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2008. Female patient, 33 years of age, weighting 149.0 lb, was diagnosed with urticaria and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, lipoatrophy, . KENALOG dosage: unknown. Patient recovered.

Byetta Side Effects Report #5796153-3
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Feb 01, 2008. Female patient, 51 years of age, was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site scab, . BYETTA dosage: unknown. Patient recovered.

Norvir Side Effects Report #5360897-8
NORVIR problem was reported by a Health Professional from FRANCE on June 08, 2007. Male patient, 46 years of age, weighting 180.8 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with NORVIR. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erosion, injection site pustule, oedema peripheral, skin ulcer, . NORVIR dosage: unknown. During the same period patient was treated with BUPRENORPHINE CHLORHYDRATE, LAMIVUDINE, TENOFOVIR DISOPROXIL, ATAZANAVIR SULPHATE, BACTRIM. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5301898-5
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on Apr 10, 2007. Female patient, 63 years of age, was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site necrosis, injection site pain, refusal of treatment by patient, scar, skin discomfort, subcutaneous abscess, wound debridement, . VOLTAREN dosage: 75 MG, UNK. Patient recovered.

Voltaren Side Effects Report #5301900-0
VOLTAREN problem was reported by a Consumer or non-health professional from BRAZIL on Apr 10, 2007. Female patient, 44 years of age, was diagnosed with renal colic and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site necrosis, injection site pain, injection site swelling, scar, skin discomfort, subcutaneous abscess, wound debridement, . VOLTAREN dosage: 75 MG, UNK. Patient recovered.

Betaseron Side Effects Report #5271473-X
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Mar 07, 2007. Female patient was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site inflammation, injection site necrosis, malnutrition, skin necrosis, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5275254-2
VELCADE problem was reported by a Pharmacist from UNITED STATES on Mar 22, 2007. Male patient, weighting 170.9 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, vein disorder, . VELCADE dosage: 1.6 MG/M2 WEEKLY (4 WEEKS ON, 1 WEEK OFF) VIA PERIPHERAL IV LINE. During the same period patient was treated with RITUXAN, FLOMAX, LANSOPRAZOLE, TOPROL, CURCUMIN. Patient recovered.

Voltaren Side Effects Report #5278443-6
Consumer or non-health professional from SAUDI ARABIA reported VOLTAREN problem on Mar 19, 2007. Female patient was diagnosed with pain, thrombosis prophylaxis and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site discolouration, injection site erythema, injection site necrosis, injection site swelling, . VOLTAREN dosage: 75 MG, QD. During the same period patient was treated with HEPARIN. Patient recovered.

Humira Side Effects Report #5668296-6
HUMIRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 18, 2008. Female patient, weighting 162.1 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: gait disturbance, injection site discolouration, injection site pain, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, CALCIUM. Patient recovered.

Humira Side Effects Report #5668497-7
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Feb 25, 2008. Male patient, weighting 250.2 lb, was diagnosed with psoriatic arthropathy and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: injection site bruising, injection site discolouration, injection site erythema, injection site inflammation, injection site nodule, injection site swelling, . HUMIRA dosage: unknown. Patient recovered.

Epipen Side Effects Report #5624110-6
EPIPEN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2007. Female patient was treated with EPIPEN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, injection site discolouration, injection site pain, injection site pallor, injection site swelling, . EPIPEN dosage: unknown. Patient recovered.

Enbrel Side Effects Report #5556318-2
Physician from UNITED STATES reported ENBREL problem on Sept 25, 2007. Female patient, weighting 154.1 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: cough, injection site discolouration, injection site irritation, injection site pain, pyrexia, rash, respiratory tract congestion, upper respiratory tract infection, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, PLAQUENIL, PREDNISONE. Patient recovered.

Byetta Side Effects Report #5576163-1
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2007. Male patient, 37 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: injection site bruising, injection site discolouration, injection site urticaria, insulin c-peptide decreased, . BYETTA dosage: unknown. During the same period patient was treated with AVANDIA, METFORMIN, GLIPIZIDE. Patient recovered.

Levemir Side Effects Report #5441634-5
Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Aug 22, 2007. Female patient was diagnosed with type 1 diabetes mellitus, thyroid disorder, depression, ill-defined disorder and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: cellulitis, injection site discolouration, pruritus, rash, . LEVEMIR dosage: unknown. During the same period patient was treated with SYNTHROID, ZOLOFT, VITAMINS NOS. Patient recovered.

Levemir Side Effects Report #5464013-3
LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2007. Female patient was diagnosed with type 1 diabetes mellitus, thyroid disorder, depression, ill-defined disorder and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: cellulitis, injection site discolouration, pruritus, rash, . LEVEMIR dosage: unknown. During the same period patient was treated with SYNTHROID, ZOLOFT, VITAMINS NOS. Patient recovered.

Diclofenac Side Effects Report #5419132-4
Health Professional from INDIA reported DICLOFENAC problem on Aug 13, 2007. Female patient, 28 years of age, was treated with DICLOFENAC. After drug was administered, patient experienced the following problems/side effects: embolia cutis medicamentosa, injection site discolouration, injection site necrosis, injection site pain, scar, surgery, . DICLOFENAC dosage: unknown. During the same period patient was treated with ANTIBIOTICS. Patient recovered.

Byetta Side Effects Report #5775500-2
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2008. Female patient, 66 years of age, weighting 149.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: headache, injection site discolouration, injection site erythema, injection site haemorrhage, injection site pain, injection site swelling, migraine, . BYETTA dosage: unknown. Patient recovered.

Exenatide Side Effects Report #5777423-1
Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Feb 11, 2008. Female patient, 59 years of age, weighting 187.0 lb, was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, injection site discolouration, nausea, retching, weight decreased, . EXENATIDE dosage: unknown. During the same period patient was treated with AMARYL, GLUCOPHAGE, ACTOS, LEVEMIR, CINNAMON, ASPIRIN. Patient recovered.

Ultravist Side Effects Report #5698913-6
ULTRAVIST problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 62 years of age, was diagnosed with nuclear magnetic resonance imaging and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: dizziness, injection site discolouration, injection site pain, phlebitis, . ULTRAVIST dosage: unknown. During the same period patient was treated with MAGNEVIST, BENADRYL, TYLENOL. Patient recovered.

Lovenox Side Effects Report #5714516-9
Health Professional from UNITED STATES reported LOVENOX problem on Apr 18, 2008. Male patient, 59 years of age, was treated with LOVENOX. After drug was administered, patient experienced the following problems/side effects: body temperature increased, injection site discolouration, injection site erythema, injection site irritation, injection site pain, injection site reaction, wound sepsis, . LOVENOX dosage: unknown. During the same period patient was treated with PERCOCET. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5360200-3
VOLTAREN problem was reported by a Physician from FRANCE on June 04, 2007. Female patient, 48 years of age, was diagnosed with back pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discolouration, injection site fibrosis, injection site reaction, . VOLTAREN dosage: 75 MG, UNK. During the same period patient was treated with COLTRAMYL. Patient recovered.

Rebif Side Effects Report #5366653-9
Physician from UNITED STATES reported REBIF problem on June 08, 2007. Female patient, 52 years of age, weighting 138.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: convulsion, injection site discolouration, injection site irritation, injection site pain, injection site reaction, weight decreased, . REBIF dosage: unknown. Patient recovered.

Omnipaque Side Effects Report #5292714-9
OMNIPAQUE problem was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 48 years of age, was treated with OMNIPAQUE. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, injection site discolouration, injection site extravasation, . OMNIPAQUE dosage: 75 ML, SINGLE, DOSE, EXTRAVASATION. Patient recovered.

Voltaren Side Effects Report #5301902-4
Consumer or non-health professional from BRAZIL reported VOLTAREN problem on Apr 10, 2007. Female patient, 57 years of age, was diagnosed with musculoskeletal pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: hypokinesia, injection site discolouration, injection site movement impairment, injection site necrosis, injection site pain, muscle necrosis, paraesthesia, scar, skin disorder, . VOLTAREN dosage: 75 MG/DAY. Patient was hospitalized. Patient recovered.

Byetta Side Effects Report #5246334-2
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Female patient, 44 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, injection site discolouration, injection site pain, injection site pruritus, . BYETTA dosage: unknown. Patient recovered.

Humira Side Effects Report #5665294-3
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on Feb 19, 2008. Female patient, weighting 152.1 lb, was diagnosed with crohn's disease, asthma, migraine, blood calcium decreased, pain and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: cutaneous lupus erythematosus, eye pruritus, injection site discolouration, injection site erythema, injection site rash, injection site warmth, skin lesion, . HUMIRA dosage: unknown. During the same period patient was treated with ADVAIR, GABAPENTIN, PREDNISONE, ALBUTEROL, CALCIUM, VICODIN. Patient recovered.

Betaseron Side Effects Report #5687883-2
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Male patient, 57 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: cellulitis, injection site cellulitis, injection site discolouration, injection site reaction, thrombosis, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Arixtra Side Effects Report #5615076-3
Consumer or non-health professional from UNITED STATES reported ARIXTRA problem on July 18, 2007. Male patient, 85 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: blood urine present, injection site bruising, injection site discolouration, pain, . ARIXTRA dosage: 7.5MG PER DAY. During the same period patient was treated with ARICEPT, NAMENDA, TORSEMIDE, SPIRIVA. Patient recovered.

Epipen Side Effects Report #5624043-5
EPIPEN problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient was diagnosed with hypersensitivity and was treated with EPIPEN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, cyanosis, injection site discolouration, paraesthesia, vasoconstriction, . EPIPEN dosage: .3 MG, SINGLE. Patient recovered.

Epipen Side Effects Report #5624056-3
Physician from UNITED STATES reported EPIPEN problem on May 24, 2007. Female patient was treated with EPIPEN. After drug was administered, patient experienced the following problems/side effects: accidental exposure, injection site discolouration, injection site pallor, . EPIPEN dosage: unknown. Patient recovered.

Keppra Side Effects Report #5614622-3
KEPPRA problem was reported by a Pharmacist from UNITED STATES on Jan 16, 2008. Male patient, 69 years of age, was diagnosed with convulsion and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: erythema, infusion site extravasation, injection site discolouration, injection site erythema, injection site reaction, injection site swelling, oedema peripheral, pneumonia, . KEPPRA dosage: unknown. During the same period patient was treated with PEPCID, ZOLOFT. Patient was hospitalized. Patient recovered.

Rebif Side Effects Report #5535351-0
Consumer or non-health professional from UNITED STATES reported REBIF problem on Nov 21, 2007. Female patient, 27 years of age, weighting 162.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, injection site discolouration, injection site mass, . REBIF dosage: unknown. Patient recovered.